Suellen M Samson

Title: Suellen M Samson: Innovator in Recombinant DNA Technology

Introduction

Suellen M Samson is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA expression vectors. With a total of 2 patents, her work has advanced the understanding and application of genetic engineering.

Latest Patents

Samson's latest patents include groundbreaking inventions related to recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase. These inventions provide DNA compounds that encode the expandase/hydroxylase enzyme, which can be utilized to construct recombinant DNA expression vectors for various host cells, including Penicillium and Cephalosporium. Another notable patent comprises novel DNA compounds that encode isopenicillin N synthetase, along with related methods, transformants, and polypeptides. This invention has led to the construction of E. coli expression vectors that drive the expression of a stable, active, and novel isopenicillin N synthetase.

Career Highlights

Samson's career is marked by her innovative research and development in the field of biotechnology. She has worked at Eli Lilly and Company, where her contributions have been instrumental in advancing the company's research initiatives. Her expertise in recombinant DNA technology has positioned her as a key figure in the industry.

Collaborations

Throughout her career, Samson has collaborated with notable colleagues, including Thomas D Ingolia and Stephen W Queener. These collaborations have further enriched her research and have led to significant advancements in the field.

Conclusion

Suellen M Samson's work in recombinant DNA technology exemplifies the impact of innovation in biotechnology. Her patents and contributions continue to influence the field, showcasing her dedication to advancing scientific knowledge and applications.